Lauxera Capital Partners SAS

https://www.lauxera.com

LinkedIn: https://www.linkedin.com/company/lauxera-capital-partners

Founded in January 2020, Lauxera Capital Partners is an independent asset management company based in France (Paris) and in the United States (San Francisco). Lauxera is a healthcare specialist investor working to promote the growth of European Healthtech companies. Its first fund, Lauxera Growth I, was reserved for professional investors and obtained the French government's “Tibi” label within the framework of the institutional investors’ charter for the financing of technology companies. Led by a team of life sciences business builders and professional healthcare investors with more than 50 years experience, Lauxera aims to support the international commercial expansion of Europe's most promising Healthtech innovations. *

	Start	2020-01-01 established
	Group	Lauxera (Group)
	Industry	venture capital
	Industry 2	MedTech (medical technology)
	Person	Moustial, Pierre (Lauxera Capital Partners 2020– President + Co-Founder before CEO of URGo + CEO of Fournier Pharma)
	Person 2	Levy, Samuel (Lauxera Capital 202007 Founding Partner)

	Region	Paris
	Country	France
	Street	121 avenue des Champs-Élysées
	City	75008 Paris
	Tel	+33-1-5357-2917
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA.

		Record changed: 2024-08-28